Haruka Otake

2PUBLICATIONS
2CO-AUTHORS
Biologically active moleculesSports science and exercise not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 23, 2026
Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab.

Haruka Otake, Satohiro Matsumoto, Hirosato Mashima

|Aug 22, 2020
Efficacy of Ustekinumab Against Spondyloarthritis Associated with Crohn's Disease: A Case Report and Review of the Literature.

Satohiro Matsumoto, Keita Matsumoto, Hiromu Takaya

Pageof 1